New SEC Form D filing

Ratio Therapeutics, Inc., 2026-07-31

A new SEC Form D private-offering notice from Boston, MA, a $69,999,974 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Ratio Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage oncology company developing targeted radiopharmaceuticals for cancer diagnosis and treatment

Filed 2026-07-31Filed to raise $69,999,974First money in 2026-07-16Raised so far $69,999,974HQ (as filed) Boston, MASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified ratiotx.com↗Named in the filing 9 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source